Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/article/10.1007/s40265-017-0756-7/fulltext.html
Reference28 articles.
1. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393–407.
2. Lacy BE. Emerging treatments in neurogastroenterology: eluxadoline—a new therapeutic option for diarrhea-predominant IBS. Neurogastroenterol Motil. 2016;28(1):26–35.
3. Breslin HJ, Diamond CJ, Kavash RW, et al. Identification of a dual δ OR antagonist/µ OR agonist as a potential therapeutic for diarrhea-predominant irritable bowel syndrome (IBS-d). Bioorg Med Chem Lett. 2012;22(14):4869–72.
4. European Medicines Agency. Truberzi (eluxadoline): EU summary of product characteristics. 2016. http://www.ema.europa.eu/ . Accessed 1 Feb 2017.
5. Wade PR, Palmer JM, McKenney S, et al. Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/µ opioid receptor antagonist. Br J Pharmacol. 2012;167(5):1111–25.
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants;Clinical Pharmacology in Drug Development;2022-08-08
2. Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease;Mucosal Immunology;2022-08
3. Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis;Frontiers in Pharmacology;2022-02-23
4. Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome;Current Opinion in Infectious Diseases;2020-08-22
5. Degradation behavior of eluxadoline under stress conditions: Structural interpretation of novel degradants using high resolution mass spectrometry and nuclear magnetic resonance;Materials Today: Proceedings;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3